drug
metformin
Preclinicalupdated 6mo agoby $CUBTD Curative Biotechnology Inc
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval48 co-mentions · 22 sources
- drugSITAGLIPTIN AND METFORMIN HYDROCHLORIDE35 co-mentions · 26 sources
- drugmetformin hydrochloride SR33 co-mentions · 26 sources
- drugmetformin hydrochloride ER33 co-mentions · 26 sources
- drugmetformin hydrochloride33 co-mentions · 26 sources
- tagSmall Molecule22 co-mentions · 21 sources
- drugDAPAGLIFLOZIN22 co-mentions · 10 sources
- drugDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE22 co-mentions · 10 sources
indications
indications
AMD
all catalysts(1)
Trials studying metformin
- phase3The Efficacy and Safety of DLBS3233 in Adults With Prediabetes
- phase1Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets
- phase1Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the Body
- phase1Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
- phase2A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- phase1A Study of LY3526318 in Healthy Male Japanese Participants
- phase1To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
- phase1Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects
News(3)
- Lilly’s retatrutide trounces Novo’s Ozempic in diabetes, weight lossEli Lilly’s next-gen weight loss drug retatrutide soundly beat Novo’s approved medicine Ozempic in weight loss and blood sugar reduction, padding the case for a regulatory application that’s expect…biospace · 19d ago
- Lilly’s retatrutide bests Ozempic on blood sugar, weight loss in phase 3 diabetes showdownEli Lilly’s triple-G drug candidate retatrutide has beaten Novo’s Ozempic in a head-to-head phase 3 trial, driving deeper reductions in blood sugar and body weight across the 80-week study.fiercebiotech · 20d ago
- After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenGrowing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence and low diagnosis.stat · 3mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that